当前位置: X-MOL 学术Circ. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Two-Year Results of a Multicenter Prospective Observational Study of the Zenith Spiral-Z Limb Deployed in the External Iliac Artery During Endovascular Aneurysm Repair.
Circulation Journal ( IF 3.3 ) Pub Date : 2020-09-25 , DOI: 10.1253/circj.cj-20-0195
Naoki Fujimura 1 , Tomohiro Imazuru 2 , Hitoshi Matsumura 3 , Tsuyoshi Shibata 4 , Tadashi Furuyama 5 , Kenjiro Kaneko 6 , Hidetoshi Uchiyama 7 , Noriyasu Morikage 8 , Takayuki Uchida 9 , Eiichi Teshima 10 , Terutoshi Yamaoka 11 , Hiroshi Masuhara 12 , Hideki Ueda 13 , Mamoru Arakawa 14 , Togo Norimatsu 15 , Hideaki Obara 16 , Seiji Onitsuka 17
Affiliation  

Background:Limited data is available on the use of a polyester graft limb with a helical stent configuration deployed in the external iliac artery (EIA) during endovascular aneurysm repair (EVAR), so we prospectively analyzed the efficacy of the Zenith Spiral-Z limb deployed in the EIA.

Methods and Results:Patients undergoing EVAR using a Zenith stent-graft and Spiral-Z limb deployed in the EIA were prospectively registered in 24 Japanese institutions from June 2017 to November 2017. In total, 65 patients (74 limbs) (mean age: 77.1±8.0 years, 87.7% men, mean abdominal aortic aneurysm (AAA) diameter: 51.9±7.2 mm, mean iliac artery aneurysm (IAA) diameter: 38.3±10.0 mm) were registered and followed up. The most common reason for deployment in the EIA was a common IAA (43 limbs, 58.1%), and 8 limbs (10.8%) had a bare nitinol stent placed at the Spiral-Z limb. A total of 61 patients (70 limbs) completed a 24-month follow-up. There were 2 Spiral-Z limb stenoses and 1 occlusion, leading to a primary patency of 95.5% and a secondary patency of 100%, at 24 months. Buttock claudication occurred in 24.3% of the limbs treated at 1 month but decreased to 4.3% at 24 months.

Conclusions:Our multicenter prospective study showed that Spiral-Z limb deployed in the EIA was associated with satisfactory results and seems to be a durable option, even in the era of iliac branch devices.



中文翻译:

血管内动脉瘤修复期间在髂外动脉中部署的 Zenith Spiral-Z 肢体的多中心前瞻性观察研究的两年结果。

背景:关于在血管内动脉瘤修复 (EVAR) 期间使用在髂外动脉 (EIA) 中部署的螺旋支架配置的聚酯移植肢体的数据有限,因此我们前瞻性地分析了部署的 Zenith Spiral-Z 肢体的功效在环境影响评估中。

方法和结果:从 2017 年 6 月到 2017 年 11 月,在 EIA 中使用 Zenith 支架移植物和 Spiral-Z 肢体进行 EVAR 的患者在 24 家日本机构进行了前瞻性登记。 总共 65 名患者(74 条肢体)(平均年龄:77.1±8.0 岁, 87.7% 的男性,平均腹主动脉瘤 (AAA) 直径:51.9±7.2 毫米,平均髂动脉瘤 (IAA) 直径:38.3±10.0 毫米)被登记和随访。在 EIA 中部署的最常见原因是常见的 IAA(43 个肢体,58.1%),并且 8 个肢体(10.8%)在 Spiral-Z 肢体处放置了裸镍钛合金支架。共有 61 名患者(70 条肢体)完成了 24 个月的随访。在 24 个月时,有 2 处 Spiral-Z 肢体狭窄和 1 处闭塞,导致 95.5% 的主要通畅率和 100% 的次要通畅率。24.3% 的肢体在 1 个月时出现臀部跛行,但下降到 4。

结论:我们的多中心前瞻性研究表明,在 EIA 中部署的 Spiral-Z 肢体与令人满意的结果相关,并且似乎是一种持久的选择,即使在髂支装置时代也是如此。

更新日期:2020-09-25
down
wechat
bug